Tag: Nasdaq:CHRS

Coherus Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update

– LOQTORZI net revenue was $10.0 million, a 36% increase over Q1 2025 –

Coherus Oncology to Report Second Quarter 2025 Financial Results on August 7, 2025

REDWOOD CITY, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (Coherus, Coherus Oncology or the Company, Nasdaq: CHRS), today announced that its second quarter 2025 financial results will be released after market close on Thursday, August 7, 2025. Starting at 5:00 p.m. EDT on August 7, 2025, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsNasdaq:CHRS

Thian Ong Financial Academy Shares AI Development Insights at Science x AI Summit 2026

NORTH ATLANTIC ENERGIES : Point sur l’offre publique d’achat simplifiée sur les actions North Atlantic Energies

Rubicon Organics to Present at Planet MicroCap Las Vegas Powered by MicroCapClub

Tag: Nasdaq:CHRS

Coherus Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update

Coherus Oncology to Report Second Quarter 2025 Financial Results on August 7, 2025

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us